In 2007, Mr. Pitts and Andrea Rabney established Argot Partners as a life scienced-focused strategic communications consultancy to provide clients with a full suite of communications services to help communicate their narratives to key audiences at every stage of the biopharmaceutical lifecycle.

Mr. Pitts co-founded Argot Partners with Ms. Rabney after their close collaboration at ImClone Systems (acquired by Eli Lilly and Company), where they navigated communications for the regulatory failure and ultimate approval of the cancer treatment ERBITUX®, various government investigations, an exploration of strategic alternatives and a consent solicitation by investor Carl Icahn. Mr. Pitts worked for ImClone as a special situations advisor, and subsequently joined the company in 2004.

Mr. Pitts began his career in corporate communications at boutique special situations firm, Sard Verbinnen & Company, and later joined the Abernathy MacGregor Group, ultimately serving as a Senior Vice President. In these roles, he counseled multi-national clients through such matters as mergers and acquisitions, corporate crises, restructurings, proxy contests, initial public offerings, exchange listings and litigation.
 Mr. Pitts earned his Bachelor of Arts degree in Asian Studies from Trinity College in Connecticut where he graduated with honors and thesis distinctions. He is fluent in French and proficient in Mandarin and Spanish.

Select Achievements

• Advised on numerous transformative communications scenarios in the life sciences, including initial public offerings, key data readouts, regulatory reviews and approval, advisory committees, product launches and M&A